Eric Pamer to Humans
This is a "connection" page, showing publications Eric Pamer has written about Humans.
Connection Strength
1.243
-
Protection against Clostridioides difficile disease by a naturally avirulent strain. Cell Host Microbe. 2025 Jan 08; 33(1):59-70.e4.
Score: 0.031
-
Gut microbes fend off harmful bacteria by depriving them of nutrients. Nature. 2024 Sep; 633(8031):774-775.
Score: 0.031
-
Translating Microbiome Research From and To the Clinic. Annu Rev Microbiol. 2022 09 08; 76:435-460.
Score: 0.026
-
Microbiome-based therapeutics. Nat Rev Microbiol. 2022 06; 20(6):365-380.
Score: 0.025
-
Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity. Cell Host Microbe. 2020 07 08; 28(1):134-146.e4.
Score: 0.023
-
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019 08; 572(7771):665-669.
Score: 0.022
-
Enlisting commensal microbes to resist antibiotic-resistant pathogens. J Exp Med. 2019 01 07; 216(1):10-19.
Score: 0.020
-
Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 2019 01; 12(1):1-9.
Score: 0.020
-
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017 Sep; 279(1):90-105.
Score: 0.019
-
Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence. mBio. 2017 08 08; 8(4).
Score: 0.019
-
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections. Annu Rev Microbiol. 2017 09 08; 71:157-178.
Score: 0.019
-
Bacterial pathogens: A spoonful of sugar could be the medicine. Nature. 2017 06 22; 546(7659):479-480.
Score: 0.019
-
Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 2017 Jul 03; 214(7):1973-1989.
Score: 0.018
-
Microbial Tuning of the Mammalian Immune System. Trends Mol Med. 2017 05; 23(5):379-380.
Score: 0.018
-
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016 10; 14(10):609-20.
Score: 0.018
-
Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med. 2016 08 15; 194(4):450-63.
Score: 0.017
-
Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates. Anaerobe. 2016 Oct; 41:32-36.
Score: 0.017
-
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016 06; 22(6):458-478.
Score: 0.017
-
Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016 Apr 29; 352(6285):535-8.
Score: 0.017
-
Microbiome mediation of infections in the cancer setting. Genome Med. 2016 Apr 18; 8(1):40.
Score: 0.017
-
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease. Cell. 2015 Dec 03; 163(6):1326-32.
Score: 0.017
-
Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol. 2015 Jun-Sep; 28(2-3):155-61.
Score: 0.017
-
Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol. 2015; 33:227-56.
Score: 0.016
-
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015 Jan 08; 517(7533):205-8.
Score: 0.015
-
Monocytes and infection: modulator, messenger and effector. Immunobiology. 2015 Feb; 220(2):210-4.
Score: 0.015
-
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014 Aug 14; 124(7):1174-82.
Score: 0.015
-
Commensal bacteria mediated defenses against pathogens. Curr Opin Immunol. 2014 Aug; 29:16-22.
Score: 0.015
-
Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections. Nat Med. 2014 Mar; 20(3):246-7.
Score: 0.015
-
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014 Mar; 7(2):210-4.
Score: 0.015
-
Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013 Nov; 13(11):790-801.
Score: 0.014
-
Cuffed and exposed--perp-walking bradyrhizobium. N Engl J Med. 2013 Aug 08; 369(6):572-4.
Score: 0.014
-
The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis. 2013 Aug; 26(4):332-7.
Score: 0.014
-
Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med. 2013 Mar; 19(3):372-7.
Score: 0.014
-
Editorial overview. Curr Opin Immunol. 2012 Aug; 24(4):361-3.
Score: 0.013
-
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012 Oct; 55(7):905-14.
Score: 0.013
-
Antibiotics, microbiota, and immune defense. Trends Immunol. 2012 Sep; 33(9):459-66.
Score: 0.013
-
Innate immune signaling in defense against intestinal microbes. Immunol Rev. 2012 Jan; 245(1):113-31.
Score: 0.013
-
Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv Immunol. 2012; 113:119-34.
Score: 0.013
-
Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe. 2011 Oct 20; 10(4):311-23.
Score: 0.013
-
Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011 Oct 10; 11(11):762-74.
Score: 0.012
-
Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol. 2011 Jun; 23(3):353-60.
Score: 0.012
-
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010 Dec; 120(12):4332-41.
Score: 0.012
-
Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol. 2009 Aug 15; 183(4):2678-87.
Score: 0.011
-
Tipping the balance in favor of protective immunity during influenza virus infection. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):4961-2.
Score: 0.010
-
Coordinating innate immune cells to optimize microbial killing. Immunity. 2008 Nov 14; 29(5):672-4.
Score: 0.010
-
TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med. 2008 Oct 23; 359(17):1836-8.
Score: 0.010
-
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis. 2008 Jul 15; 198(2):176-85.
Score: 0.010
-
Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008; 26:421-52.
Score: 0.010
-
Immune responses to commensal and environmental microbes. Nat Immunol. 2007 Nov; 8(11):1173-8.
Score: 0.010
-
Cracking the fungal armor. Nat Med. 2006 Jul; 12(7):730-2.
Score: 0.009
-
Immunity to fungi. Curr Opin Immunol. 2006 Aug; 18(4):465-72.
Score: 0.009
-
Immune responses to Aspergillus fumigatus infections. Biol Blood Marrow Transplant. 2006 Jan; 12(1 Suppl 1):47-9.
Score: 0.008
-
Subspecies phylogeny in the human gut revealed by co-evolutionary constraints across the bacterial kingdom. Cell Syst. 2025 Feb 19; 16(2):101167.
Score: 0.008
-
Immune responses to Listeria monocytogenes. Nat Rev Immunol. 2004 Oct; 4(10):812-23.
Score: 0.008
-
Comprehensive analyses of a large human gut Bacteroidales culture collection reveal species- and strain-level diversity and evolution. Cell Host Microbe. 2024 Oct 09; 32(10):1853-1867.e5.
Score: 0.008
-
Intestinal carbapenem-resistant Klebsiella pneumoniae undergoes complex transcriptional reprogramming following immune activation. Gut Microbes. 2024 Jan-Dec; 16(1):2340486.
Score: 0.007
-
T cell responses to Listeria monocytogenes. Curr Opin Microbiol. 2004 Feb; 7(1):45-50.
Score: 0.007
-
Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals. ACS Chem Biol. 2024 02 16; 19(2):357-369.
Score: 0.007
-
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2024 Jan; 9(1):55-69.
Score: 0.007
-
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
Score: 0.007
-
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
Score: 0.007
-
Quantitative studies of CD8+ T-cell responses during microbial infection. Curr Opin Immunol. 2003 Aug; 15(4):436-42.
Score: 0.007
-
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia. Cell Host Microbe. 2023 07 12; 31(7):1126-1139.e6.
Score: 0.007
-
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell. 2023 06 08; 186(12):2705-2718.e17.
Score: 0.007
-
Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature. 2023 01; 613(7945):639-649.
Score: 0.007
-
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.
Score: 0.007
-
Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus. J Clin Invest. 2002 Nov; 110(10):1493-501.
Score: 0.007
-
Homeostasis of naïve, effector and memory CD8 T cells. Curr Opin Immunol. 2002 Jun; 14(3):348-53.
Score: 0.007
-
A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients. Sci Data. 2022 05 18; 9(1):219.
Score: 0.007
-
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022 04; 28(4):713-723.
Score: 0.006
-
CD8 T cell responses to infectious pathogens. Annu Rev Immunol. 2003; 21:29-70.
Score: 0.006
-
Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria. Clin Infect Dis. 2021 12 06; 73(11):e4627-e4635.
Score: 0.006
-
A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microb Genom. 2021 06; 7(6).
Score: 0.006
-
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021 03 18; 137(11):1527-1537.
Score: 0.006
-
Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data. 2021 03 02; 8(1):71.
Score: 0.006
-
Cervicovaginal bacterial communities in reproductive-aged Tanzanian women with Schistosoma mansoni, Schistosoma haematobium, or without schistosome infection. ISME J. 2021 05; 15(5):1539-1550.
Score: 0.006
-
Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000 Oct 15; 96(8):2814-21.
Score: 0.006
-
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood. 2020 07 02; 136(1):130-136.
Score: 0.006
-
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 02 27; 382(9):822-834.
Score: 0.006
-
Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):81-89.
Score: 0.006
-
Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019 12 04; 10(1):5521.
Score: 0.005
-
Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol Rev. 1999 Dec; 172:163-9.
Score: 0.005
-
Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019 11 29; 366(6469):1143-1149.
Score: 0.005
-
Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients. Transpl Infect Dis. 2019 Dec; 21(6):e13167.
Score: 0.005
-
Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. Transpl Infect Dis. 2019 Dec; 21(6):e13180.
Score: 0.005
-
T cell responses to bacterial infection. Curr Opin Immunol. 1999 Aug; 11(4):400-5.
Score: 0.005
-
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv. 2019 07 09; 3(13):2040-2044.
Score: 0.005
-
Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination. Infect Immun. 2019 07; 87(7).
Score: 0.005
-
Antigen presentation in the immune response to infectious diseases. Clin Infect Dis. 1999 Apr; 28(4):714-6.
Score: 0.005
-
The role of CD1-restricted T cells in infectious diseases. Trends Microbiol. 1999 Jan; 7(1):13.
Score: 0.005
-
Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019 01 07; 216(1):84-98.
Score: 0.005
-
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med. 2018 09 26; 10(460).
Score: 0.005
-
The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota. Int J Nanomedicine. 2018; 13:5275-5286.
Score: 0.005
-
A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity. Sci Transl Med. 2018 08 15; 10(454).
Score: 0.005
-
Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant. 2019 02; 19(2):488-500.
Score: 0.005
-
Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med. 1998 Jul 06; 188(1):61-70.
Score: 0.005
-
Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018 06 28; 131(26):2978-2986.
Score: 0.005
-
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018 04 10; 2(7):745-753.
Score: 0.005
-
Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol. 1998; 16:323-58.
Score: 0.005
-
Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression. Cancer Res. 2017 11 15; 77(22):6400-6414.
Score: 0.005
-
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Cancer Causes Control. 2017 Sep; 28(9):959-969.
Score: 0.005
-
Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2017 04 01; 215(7):1117-1123.
Score: 0.005
-
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol. 2017 May 20; 35(15):1650-1659.
Score: 0.005
-
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 May; 23(5):845-852.
Score: 0.005
-
Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother. 2017 01; 72(1):128-136.
Score: 0.004
-
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
Score: 0.004
-
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520.
Score: 0.004
-
Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology. J Clin Microbiol. 2016 Jul; 54(7):1686-1693.
Score: 0.004
-
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016 Feb 02; 7:10391.
Score: 0.004
-
IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy? Science. 2015 Nov 27; 350(6264):1031-2.
Score: 0.004
-
Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):8-15.
Score: 0.004
-
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1373-83.
Score: 0.004
-
Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015; 10(3):e0122399.
Score: 0.004
-
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015 Jan; 67(1):128-39.
Score: 0.004
-
Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014 Oct 15; 98(7):697-705.
Score: 0.004
-
Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014; 9(3):e90158.
Score: 0.004
-
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013 Nov 05; 2:e01202.
Score: 0.004
-
Cellular immunity to intracellular bacteria. Curr Opin Immunol. 1993 Aug; 5(4):492-6.
Score: 0.004
-
Do nonclassical, class Ib MHC molecules present bacterial antigens to T cells? Trends Microbiol. 1993 Apr; 1(1):35-8.
Score: 0.003
-
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One. 2013; 8(1):e54302.
Score: 0.003
-
Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012 Oct; 64(10):3083-94.
Score: 0.003
-
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012 May 07; 209(5):903-11.
Score: 0.003
-
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1576-81.
Score: 0.003
-
2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010 Apr; 60(4):257-63.
Score: 0.003
-
Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant. 2009 Sep; 15(9):1130-3.
Score: 0.003
-
Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study. Biol Blood Marrow Transplant. 2008 Dec; 14(12):1429-33.
Score: 0.003
-
Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect. 2008 Dec; 57(6):464-71.
Score: 0.003
-
Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med. 2008 Sep 29; 205(10):2359-68.
Score: 0.003
-
Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis. 2008 Jun; 10(3):162-7.
Score: 0.002
-
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis. 2007 Jun; 9(2):108-13.
Score: 0.002
-
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2007 Dec; 9(4):286-94.
Score: 0.002
-
TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci. 2005 Dec; 1062:95-103.
Score: 0.002
-
Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005 Mar; 7(1):11-7.
Score: 0.002
-
Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004 Dec 01; 39(11):1625-32.
Score: 0.002
-
In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clin Cancer Res. 2004 Nov 01; 10(21):7207-19.
Score: 0.002
-
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers. Blood. 2004 Oct 15; 104(8):2397-402.
Score: 0.002
-
Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004 Jan 15; 172(2):1287-94.
Score: 0.002
-
Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Blood. 2003 Oct 01; 102(7):2498-505.
Score: 0.002
-
Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood. 2003 Jun 01; 101(11):4290-7.
Score: 0.002
-
Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest. 2002 Aug; 110(4):537-48.
Score: 0.002
-
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis. 2002 Aug 01; 35(3):E35-6.
Score: 0.002
-
Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 2002 Mar 01; 99(5):1730-40.
Score: 0.002
-
High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. J Virol. 2002 Mar; 76(6):2730-8.
Score: 0.002
-
The CD40-CD154 system in anti-infective host defense. Curr Opin Immunol. 1997 Aug; 9(4):491-7.
Score: 0.001
-
A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect Immun. 1996 May; 64(5):1685-93.
Score: 0.001